A Pediatric ITP Risk Model and Targeting CD2 with CAR T-cell therapies

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs. Kirsty Hillier and Marco Ruella on their latest articles published in Blood . For " Predicting Development of Pediatric Chronic Immune Thrombocytopenia at Disease Onset Using a Statistical Risk Model ", Dr. Hillier shares the potential benefits of incorporating this new model to enhance the care of the 1 in 4 patients who…